ELANCO ANIMAL HEALTH INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 82,920,582 | $870,666,111 | 0.50% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 14, 2025 |
| June 30, 2025 | 82,895,232 | $1,183,743,913 | 0.67% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 13, 2025 |
| Sept. 30, 2025 | 82,759,837 | $1,666,783,117 | 0.90% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 13, 2025 |
| Dec. 31, 2025 | 79,084,305 | $1,789,677,822 | 0.97% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 13, 2026 |
| March 31, 2026 | 68,944,100 | $1,649,832,313 | 0.91% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 14, 2026 |
| June 30, 2026 | 67,397,025 | $1,658,640,785 | 0.87% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 13, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
Elanco Animal Health Inc · SC 13G/A · Event March 31, 2026 · Filed May 14, 2026
| Reporting person | Reported shares | % of security class | Group box |
|---|---|---|---|
| Dodge & Cox | 68,944,100 | 13.9% | Unavailable |
Elanco Animal Health Inc · SC 13G/A · Event Dec. 31, 2025 · Filed Feb. 13, 2026
| Reporting person | Reported shares | % of security class | Group box |
|---|---|---|---|
| Dodge & Cox | 79,084,305 | 15.9% | Unavailable |
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.